Bronchiectasis

Bronchiectasis Treatment

Bronchiectasis treatment

Individuals Living With Bronchiectasis May Benefit From Cellular Treatment

Bronchiectasis treatment is designed to help people manage and live with the effects of this chronic obstructive lung condition. Periodic episodes of breathing difficulties can flare-up as inflammation develops within the airways (bronchi). Over time, this inflammation can cause the walls of the bronchi to thicken and prevent mucus from draining properly. The resulting accumulation of mucus can allow bacteria to build up in the lungs, leading to infections and scarring. Because the inflammation is cyclical, effective bronchiectasis treatment is essential not only for helping an individual breathe easier, but also for preserving respiratory function.

Traditional forms of bronchiectasis treatment include antibiotics and mucus-thinning medications and devices, all of which can vary widely in effectiveness. As an alternative treatment for bronchiectasis, the Lung Institute offers cellular therapy. This landmark therapy has the potential to improve lung function and promote healing by utilizing the power of a patient’s own cells. The most significant characteristic of cells is that they are undifferentiated, which means they have the ability to replicate themselves and then become specialized to potentially match any type of cell in the body, such as a healthy lung cell.

The Lung Institute offers two minimally invasive, outpatient stem cell procedures for bronchiectasis treatment:

  • Venous (blood-derived) cellular therapy ­– Cells are derived from a patient’s blood. After drawing a blood specimen, we separate its components in our onsite lab, then intravenously return the concentrated cells to the patient’s body.
  • Bone marrow cellular therapy – Cells are harvested from a patient’s bone marrow (a spongy substance that fills the inner cavities of bones where blood is produced). After collecting a small amount of a patient’s bone marrow fluid, we separate the cells in the sample, then intravenously reintroduce the cells to the patient’s body.

At the Lung Institute, we understand that many people who are living with chronic lung conditions simply want to be able to perform everyday tasks without feeling tired or becoming breathless. With this in mind, we have pioneered cellular therapy as an alternative bronchiectasis treatment. As the only cellular clinic in the world that focuses exclusively on treating lung disease, we continue to lead the way in helping these patients find a better quality of life.

Contact the Lung Institute today at (800) 729-3065 to learn more about our unique cellular therapies for alternative bronchiectasis treatment.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.